Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen

Core Scientific, Inc.

CORZW · Nasdaq · USD · 325 employees

Core Scientific, Inc.

FAIL · Does not pass the screen
7.79 USD

Price as of 15 Oct 2026Daily close, not a live quoteLast reviewed 32 days ago

Screened 2026-10-15 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price7.79 USD at the 15 Oct 2026 close
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed15 Oct 2026 (32 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-10-15).

Current read
Distribution ?
Screened · screened 2026-10-15
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price7.79 USD
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Distribution11.65-33.1% to today ✓Markup gives way to Distribution after an 18% slide in 5 weeks
2026-08-25Read Markup14.16-45.0% to today Distribution gives way to Markup while volume is distributing
2026-07-25Read Distribution14.16-45.0% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Core Scientific, Inc. holds its Distribution at $7.79. The statistical read favours the sellers, held for 13 days.

As held on the ledger · 2026-10-15
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 13 days
Price at the screen$7.79
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 70.0
Beta5.50
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 49.52% Below 33% Interest-bearing debt is 49.5% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 27.62% Below 49% Money owed to the company is 27.6% of assets, under the 49% limit. Pass
Revenue purity 1.03% Below 5% Only 1.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Core Scientific,'s business is in a permissible area, but its interest-bearing debt is about 50% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CORZW's ethical verdict changes

Today CORZW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Revenue growth+44.9%growing very fast
Profit margin0.0%currently unprofitable
Current ratio0.55below 1: short-term bills exceed liquid assets
Beta5.50much more volatile than the market
52-week range13.17 - 14.62
Employees325

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CORZW trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-08 Distribution $7.79 +0.0% Entry 6

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish.

2026-10-28 Distribution $7.79 -10.9% Entry 5

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish.

2026-10-15 Distribution $8.74 -25.0% Entry 4

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 25.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought.

2026-10-02 Distribution · changed $11.65 -17.7% Entry 3

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought.

2026-08-25 Markup · changed $14.16 +0.0% Entry 2

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought.

2026-07-25 Distribution $14.16 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $9.15 +106.7% · $2,067 +106.7%
2 months $9.15 +106.7% · $2,067 +106.7%
3 months $9.15 +106.7% · $2,067 +106.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CORZW does next, these words stay.

Core Scientific, Inc. · CORZW · Distribution · $7.79
Recorded 2026-10-15 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.